Indefinite Delivery Contract SPE2DR25D1004

The Indefinite Delivery Contract (IDC) SPE2DR25D1004 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, aims to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contract encompasses a 30-month base period with three 30-month option periods, for a total estimated value of $30.3 billion. The contract will cover a broad range of pharmaceutical products, including brand-name, generic, and specialty medications, as well as medical supplies such as syringes, vials, and test kits. The contract will support normal day-to-day operations, planned and unplanned contingencies, Prime Vendor Readiness, and War Readiness Materiel for both CONUS and OCONUS locations. The solicitation was issued as an unrestricted, fully competitive acquisition, with the intent to make multiple awards to ensure the DoD's resiliency and access to vital pharmaceuticals during times of contingency or natural disasters.